• IPO on the SWX Swiss Exchange

    €74.3m raised - one of the top 3 global biotech IPOs of this year

  • from 2000 to 2005

    • 3 rounds of VC funding: 3i, Atlas, Apax, HBM, TVM for a total of €63m
    • US IND approval for safinamide in Parkinson's disease

  • Newron established; acquisition of assets from Pharmacia & Upjohn